P3 Health Partners Inc. (PIIIW)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 199.56 Million USD | -91.29% |
| 2022 | 1.29 Billion USD | -99.75% |
| 2021 | 519.65 Billion USD | 99705.88% |
| 2020 | 520.66 Million USD | 181.41% |
| 2019 | 185.01 Million USD | 34.65% |
| 2018 | 137.41 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 28.72 Million USD | 31.71% |
| 2024 Q2 | 23.62 Million USD | 57.78% |
| 2023 FY | 112.82 Million USD | -91.29% |
| 2023 Q2 | 350.11 Million USD | -0.22% |
| 2023 Q4 | 21.8 Million USD | -93.23% |
| 2023 Q3 | 322.17 Million USD | -7.98% |
| 2023 Q1 | 350.89 Million USD | 5.91% |
| 2022 FY | 1.29 Billion USD | -99.75% |
| 2022 Q4 | 331.3 Million USD | 7.47% |
| 2022 Q3 | 308.27 Million USD | -6.64% |
| 2022 Q2 | 330.18 Million USD | 1.37% |
| 2022 Q1 | 325.71 Million USD | -99.94% |
| 2021 Q1 | 164.28 Million USD | 12800.18% |
| 2021 FY | 519.65 Billion USD | 99705.88% |
| 2021 Q4 | 519.13 Billion USD | 281053.1% |
| 2021 Q3 | 184.64 Million USD | 8.07% |
| 2021 Q2 | 170.85 Million USD | 4.0% |
| 2020 Q4 | 1.27 Million USD | -91.7% |
| 2020 Q2 | 121.52 Million USD | 2060.8% |
| 2020 Q1 | 5.62 Million USD | 0.0% |
| 2020 Q3 | 15.33 Million USD | -87.38% |
| 2020 FY | 520.66 Million USD | 181.41% |
| 2019 FY | 185.01 Million USD | 34.65% |
| 2018 FY | 137.41 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 176.01 Million USD | -13.381% |
| Addus HomeCare Corporation | 248.92 Million USD | 19.828% |
| AirSculpt Technologies, Inc. | 118.32 Million USD | -68.663% |
| Amedisys, Inc. | 834.47 Million USD | 76.085% |
| American Oncology Network, Inc. | 83.97 Million USD | -137.648% |
| Astrana Health, Inc. | 112.59 Million USD | -77.238% |
| Aveanna Healthcare Holdings Inc. | 587.36 Million USD | 66.023% |
| IMAC Holdings, Inc. | 5.02 Million USD | -3869.763% |
| biote Corp. | 98.82 Million USD | -101.936% |
| Cryo-Cell International, Inc. | 35.2 Million USD | -466.859% |
| Cross Country Healthcare, Inc. | 337.69 Million USD | 40.904% |
| COMPASS Pathways plc | 136.91 Million USD | -45.754% |
| DocGo Inc. | 180.32 Million USD | -10.668% |
| The Ensign Group, Inc. | 335.39 Million USD | 40.498% |
| Healthcare Services Group, Inc. | 189.09 Million USD | -5.539% |
| InnovAge Holding Corp. | 558.25 Million USD | 64.252% |
| Assure Holdings Corp. | 15.43 Million USD | -1192.603% |
| The Joint Corp. | 109.22 Million USD | -82.714% |
| LifeStance Health Group, Inc. | 491.23 Million USD | 59.374% |
| Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | -993.979% |
| ModivCare Inc. | 586.89 Million USD | 65.997% |
| NewGenIvf Group Limited | 1.63 Million USD | -12071.989% |
| Novo Integrated Sciences, Inc. | 13.5 Million USD | -1377.616% |
| Option Care Health, Inc. | 666.62 Million USD | 70.064% |
| P3 Health Partners Inc. | 199.56 Million USD | 0.0% |
| The Pennant Group, Inc. | 88.99 Million USD | -124.243% |
| Surgery Partners, Inc. | 319.5 Million USD | 37.538% |
| Syra Health Corp. Class A Common Stock | 4.29 Million USD | -4541.587% |
| Talkspace, Inc. | 97.58 Million USD | -104.495% |
| Talkspace, Inc. | 97.58 Million USD | -104.495% |
| The Oncology Institute, Inc. | 136.59 Million USD | -46.104% |
| The Oncology Institute, Inc. | 136.59 Million USD | -46.104% |